“…Of the 14 case-control studies, eight studies were conducted in Asia ( 25 – 28 , 30 – 33 ), two in Europe ( 10 , 29 ), two in North America ( 9 , 23 ), one in Africa ( 24 ), and one in South America ( 22 ). As to study design, most of these studies were population-based controls ( 9 , 22 , 23 , 26 , 30 , 33 ), and the remaining six studies used a hospital-based case-control design ( 10 , 24 , 25 , 27 – 29 , 31 , 32 ). Moreover, seven studies examined the association between chili pepper intake and the risk of GC ( 9 , 10 , 22 , 23 , 25 , 27 , 28 ), three on CRC ( 29 , 32 , 33 ), and four on EC ( 24 , 26 , 30 , 31 ).…”